225 related articles for article (PubMed ID: 31062644)
1. Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in
Sheffels E; Sealover NE; Theard PL; Kortum RL
Small GTPases; 2021 Jan; 12(1):67-78. PubMed ID: 31062644
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
3. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
[TBL] [Abstract][Full Text] [Related]
4. The Role of Wild-Type RAS in Oncogenic RAS Transformation.
Sheffels E; Kortum RL
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33924994
[TBL] [Abstract][Full Text] [Related]
5. SOS2 regulates the threshold of mutant
Theard PL; Linke AJ; Sealover NE; Daley BR; Yang J; Cox K; Kortum RL
bioRxiv; 2023 Jun; ():. PubMed ID: 37425733
[TBL] [Abstract][Full Text] [Related]
6. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
7. SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.
Baltanás FC; García-Navas R; Santos E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205562
[TBL] [Abstract][Full Text] [Related]
8. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
Huang L; Counter CM
PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
[TBL] [Abstract][Full Text] [Related]
9. Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.
Nigam A; Krishnamoorthy G; Chatila W; Berman K; Saqcena M; Walch H; Ho A; Schultz N; Fagin J; Untch B
Res Sq; 2023 Jul; ():. PubMed ID: 37503077
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.
Nussinov R; Zhang M; Tsai CJ; Jang H
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261
[TBL] [Abstract][Full Text] [Related]
11. Argonaute 2 modulates EGFR-RAS signaling to promote mutant
Siebenaler RF; Chugh S; Waninger JJ; Dommeti VL; Kenum C; Mody M; Gautam A; Patel N; Chu A; Bawa P; Hon J; Smith RD; Carlson H; Cao X; Tesmer JJG; Shankar S; Chinnaiyan AM
PNAS Nexus; 2022 Jul; 1(3):pgac084. PubMed ID: 35923912
[TBL] [Abstract][Full Text] [Related]
12. Isoform-specific Ras signaling is growth factor dependent.
Hood FE; Klinger B; Newlaczyl AU; Sieber A; Dorel M; Oliver SP; Coulson JM; Blüthgen N; Prior IA
Mol Biol Cell; 2019 Apr; 30(9):1108-1117. PubMed ID: 30785867
[TBL] [Abstract][Full Text] [Related]
13. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
[TBL] [Abstract][Full Text] [Related]
14. Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis.
Baltanás FC; Mucientes-Valdivieso C; Lorenzo-Martín LF; Fernández-Parejo N; García-Navas R; Segrelles C; Calzada N; Fuentes-Mateos R; Paramio JM; Bustelo XR; Santos E
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946974
[TBL] [Abstract][Full Text] [Related]
15. The role of wild type RAS isoforms in cancer.
Zhou B; Der CJ; Cox AD
Semin Cell Dev Biol; 2016 Oct; 58():60-9. PubMed ID: 27422332
[TBL] [Abstract][Full Text] [Related]
16. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
17. Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer.
Weyandt J
Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162272
[TBL] [Abstract][Full Text] [Related]
18. Triggering Ras signalling by intracellular Francisella tularensis through recruitment of PKCα and βI to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosol.
Al-Khodor S; Abu Kwaik Y
Cell Microbiol; 2010 Nov; 12(11):1604-21. PubMed ID: 20618341
[TBL] [Abstract][Full Text] [Related]
19. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion.
Quinlan MP; Quatela SE; Philips MR; Settleman J
Mol Cell Biol; 2008 Apr; 28(8):2659-74. PubMed ID: 18268007
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography.
Smith CR; Chen D; Christensen JG; Coulombe R; Féthière J; Gunn RJ; Hollander J; Jones B; Ketcham JM; Khare S; Kuehler J; Lawson JD; Marx MA; Olson P; Pearson KE; Ren C; Tsagris D; Ulaganathan T; Van't Veer I; Wang X; Ivetac A
J Med Chem; 2024 Jan; 67(1):774-781. PubMed ID: 38156904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
